By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Catabasis Pharmaceuticals, Inc. 

161 First Street
Suite 1A
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-349-1971 Fax: 617-273-2637


SEARCH JOBS


Industry
Pharmaceutical






Company News
Catabasis (CATB) Reports Second Quarter 2017 Financial Results And Reviews Business Progress 8/11/2017 6:30:35 AM
Catabasis (CATB) To Report Second Quarter 2017 Financial Results And Recent Corporate Developments On Thursday, August 10 7/27/2017 8:16:31 AM
Catabasis (CATB) To Present Results From The Movedmd Trial Of Edasalonexent (CAT-1004) At The 2017 PPMD Annual Connect Conference 6/23/2017 7:11:21 AM
Catabasis (CATB) Presents New Data For CAT-5571 As A Novel Potential Oral Treatment For Cystic Fibrosis At The 40th European Cystic Fibrosis Society Conference 6/9/2017 7:12:51 AM
Catabasis (CATB) Presents New Data For CAT-5571 As A Novel Potential Oral Treatment For Cystic Fibrosis At The 40th European Cystic Fibrosis Society Conference 6/8/2017 11:20:43 AM
Catabasis (CATB) To Present CAT-5571, A Novel Activator Of Autophagy, As A Potential Treatment For Cystic Fibrosis At The 40th European Cystic Fibrosis Society Conference 6/2/2017 8:07:38 AM
Catabasis (CATB) Reports First Quarter 2017 Financial Results And Reviews Business Progress 5/12/2017 6:31:47 AM
Catabasis (CATB) To Report First Quarter 2017 Financial Results And Recent Corporate Developments On Thursday, May 11 4/27/2017 8:24:25 AM
Catabasis (CATB) Announces Favorable Results For Functional Assessments In The Movedmd Trial For Edasalonexent In Duchenne Muscular Dystrophy At American Academy of Neurology 69th Annual Meeting 4/25/2017 8:29:15 AM
Catabasis (CATB) Reports Fourth Quarter And Full Year 2016 Financial Results And Recent Corporate Highlights 3/17/2017 6:30:08 AM
12345678910...
//-->